Targeted nanoparticles incorporating siRNA offer promise for cancer treatment

May 20, 2007

The use of targeted nanoparticles offers promising techniques for cancer treatment. Researchers in the laboratory of Mark E. Davis at the California Institute of Technology have been using small interfering RNA (siRNA), sometimes known as silencing RNA, to "silence" specific genes that are implicated in certain malignancies.

One of the primary challenges associated with this type of therapy is delivering the therapeutic agent into the body and then to the tumor in a safe and effective manner. By using targeted nanoparticles, researchers have demonstrated that systemically delivered siRNA can slow the growth of tumors in mice without eliciting the toxicities often associated with cancer therapies. The results of this research are being presented this week at the NSTI Nanotech 2007 Conference in Santa Clara, CA.

The Caltech researchers have incorporated siRNA into nanoparticles that are formed completely by self-assembly, characterized the behavior of these nanoparticles and studied their safety and efficacy in mice.

Using extensive physicochemical and biological characterization, the investigators are able to estimate the composition of individual nanoparticles and to correlate the nanoparticle structure with its biological function. This quantitative approach provides unique insights into the design of more effective nanoparticle carriers.

According to the lead author of the study, Derek W. Bartlett, "Safe and effective delivery remains perhaps the greatest impediment to the clinical realization of small interfering RNA (siRNA) in cancer therapy. Formation of siRNA nanoparticles using cyclodextrin-containing polycations is one of the most promising strategies for systemic siRNA delivery, and such nanoparticles are expected to enter Phase I clinical trials by late 2007. Our most recent work examines the impact of various dosing schedules and surface modifications on the efficacy of these siRNA nanoparticles in preclinical cancer models. By combining the experimental data with a mathematical model of siRNA-mediated gene silencing, we illustrate several practical considerations that we believe will be directly relevant to the clinical application of siRNA-based therapeutics in cancer therapy."

Source: Elsevier Health Sciences


Rank 3 /5 (2 votes)
Tags

Relevant PhysicsForums posts
  • Stem cell question.
    createdFeb 10, 2012
  • Protease cleavage
    createdFeb 10, 2012
  • Pertubance in a model
    createdFeb 10, 2012
  • Cancer drugs and Alzheimer's, Oh my!
    createdFeb 09, 2012
  • Squishing cells
    createdFeb 09, 2012
  • Any books/articles for evolutionary stable strategy models in humans?
    createdFeb 09, 2012
  • More from Physics Forums - Biology

More news stories

New kind of solar cell could capture significantly more energy than current cells

New solar cells could increase the maximum efficiency of solar panels by over 25%, according to scientists from the University of Cambridge.

Nanotechnology / Nanophysics

created Feb 08, 2012 | popularity 4.5 / 5 (12) | comments 14 | with audio podcast

Nanoshell whispering galleries improve thin solar panels

Visitors to Statuary Hall in the U.S. Capitol Building may have experienced a curious acoustic feature that allows a person to whisper softly at one side of the cavernous, half-domed room and for another on ...

Nanotechnology / Nanomaterials

created Feb 07, 2012 | popularity 4.3 / 5 (6) | comments 6 | with audio podcast

'Dark plasmons' transmit energy

Microscopic channels of gold nanoparticles have the ability to transmit electromagnetic energy that starts as light and propagates via "dark plasmons," according to researchers at Rice University.

Nanotechnology / Nanophysics

created Feb 09, 2012 | popularity 4.8 / 5 (9) | comments 1 | with audio podcast

Revealing how a battery material works

Since its discovery 15 years ago, lithium iron phosphate (LiFePO4) has become one of the most promising materials for rechargeable batteries because of its stability, durability, safety and ability to deliver ...

Nanotechnology / Nanomaterials

created Feb 08, 2012 | popularity 5 / 5 (5) | comments 0 | with audio podcast

Nanotube therapy takes aim at breast cancer stem cells

Wake Forest Baptist Medical Center researchers have again proven that injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second laser treatment can kill them.

Nanotechnology / Bio & Medicine

created Feb 09, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast


Walney offshore wind farm is world's biggest (for now)

(PhysOrg.com) -- The Walney wind farm on the Irish Sea--characterized by high tides, waves and windy weather--officially opened this week. The farm is treated in the press as a very big deal as the Walney ...

GPS court ruling leaves US phone tracking unclear

A US Supreme Court decision requiring a warrant to place a GPS device on the car of a criminal suspect leaves unresolved the bigger issue of police tracking using mobile phones, legal experts say.

Europeans protest controversial Internet pact

Tens of thousands of people marched in protests in more than a dozen European cities Saturday against a controversial anti-online piracy pact that critics say could curtail Internet freedom.

Europe stakes billion-dollar bet on new rocket

A pencil-slim rocket is scheduled to lift into space from South America on Monday, carrying a billion-dollar bet that Europe can grab a juicy slice of the market to place satellites in low orbit.

Study finds that anti-diabetic medication can prevent the long-term effects of maternal obesity

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication ...

Netflix settlement trims 14 pct off 4Q earnings

(AP) -- Netflix pressed the rewind button on its fourth-quarter earnings after settling allegations that the video subscription service violated a consumer-privacy law.